Pharma Components ApS: Financial statements 2025
CVR: 39103079
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma Components ApS (CVR 39103079) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -35,183 and a net result of DKK -115,173 compared with DKK 142,048 the year before. Equity in the 2025 report amounted to DKK 272,393. The solvency ratio was 44%.
- Gross Profit
- DKK -35,183
- Profit/Loss
- DKK -115,173
- Equity
- DKK 272,393
- Total Assets
- DKK 619,287
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -35 t. | -115 t. | 272 t. | 0 |
| 2024 | - | 336 t. | 142 t. | 388 t. | 0 |
| 2023 | - | 232 t. | 196 t. | 246 t. | 0 |
| 2022 | - | 69 t. | 57 t. | 49 t. | 0 |
| 2021 | - | -22 t. | -23 t. | -8 t. | 0 |
How creditworthy is Pharma Components ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharma Components ApS has published its annual report for 2024. Gross profit came to DKK 336,413, and the net result was DKK 142,048.
About Pharma Components ApS
Pharma Components ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Pharma Components IVS. The management consists of Anders Fossing Riel. The company is owned by A.Rocket Holding ApS. In 2025, the company reported a gross profit of DKK -35,183 and a net result of DKK -115,173 compared with DKK 142,048 the year before. Equity in the 2025 report amounted to DKK 272,393.